• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胃源性与结直肠源性库肯勃瘤

Krukenberg tumors of gastric origin versus colorectal origin.

作者信息

Jeung Yi Jo, Ok Hee Jae, Kim Won Gyu, Kim Sung Han, Lee Tae Hwa

机构信息

Department of Obstetrics and Gynecology, Kosin University Gospel Hospital, Kosin University College of Medicine, Busan, Korea.

出版信息

Obstet Gynecol Sci. 2015 Jan;58(1):32-9. doi: 10.5468/ogs.2015.58.1.32. Epub 2015 Jan 16.

DOI:10.5468/ogs.2015.58.1.32
PMID:25629016
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4303750/
Abstract

OBJECTIVE

The aim of this study is to compare the each clinical manifestation related with its mean survival time of Krukenberg tumors (KTs) of gastric origin versus with that of colorectal origin.

METHODS

A total of 156 consecutive patients diagnosed with KTs of the ovary who underwent surgical treatment at a single institution between 2001 and 2010 were retrospectively evaluated. Each clinical manifestation related with its mean survival time compared two different groups. Survival analyses and comparisons were performed using the Kaplan-Meier method.

RESULTS

Among the 156 patients with KT, 111 patients with KTs of gastric origin and 45 patients with KTs of colorectal origin were identified. For all patients with KTs, median survival time was 22.7 months. Each mean survival time among all patients with KTs of gastric origin and colorectal origin was 19.2 months and 27.3 months. The results showed that mean survival time of postmenopausal patients was 19.0 months compared with 32.5 months for premenopausal patients (P=0.015). Among all patients, mean survival time of those with metachronous cancer was longer than those with synchronous cancer (P=0.001). In all cases, especially when only one ovary was invaded, the mean survival time was relatively higher (P=0.001).

CONCLUSION

Patients with KTs of colorectal origin had a better prognosis than those of gastric origin. In all cases of KT, the mean survival time was significantly longer in postmenoposal patients, metachronous disease and unilateral ovarian involvement. Notably, synchronous, ascites positive, and ovary only metastasis showed more longer mean survival time in the KTs of colorectal origin than KTs of gastric origin.

摘要

目的

本研究旨在比较胃源性与结直肠源性库肯勃瘤(KTs)的各临床表现及其平均生存时间。

方法

回顾性评估2001年至2010年间在单一机构接受手术治疗的156例连续诊断为卵巢KTs的患者。将各临床表现与其平均生存时间进行比较,分为两个不同组。采用Kaplan-Meier法进行生存分析和比较。

结果

在156例KT患者中,确定了111例胃源性KT患者和45例结直肠源性KT患者。所有KT患者的中位生存时间为22.7个月。胃源性和结直肠源性KT患者的平均生存时间分别为19.2个月和27.3个月。结果显示,绝经后患者的平均生存时间为19.0个月,而绝经前患者为32.5个月(P=0.015)。在所有患者中,异时性癌患者的平均生存时间长于同时性癌患者(P=0.001)。在所有病例中,尤其是仅一侧卵巢受侵时,平均生存时间相对较长(P=0.001)。

结论

结直肠源性KT患者的预后优于胃源性患者。在所有KT病例中,绝经后患者、异时性疾病和单侧卵巢受累患者的平均生存时间明显更长。值得注意的是,在结直肠源性KT中,同时性、腹水阳性和仅卵巢转移的患者平均生存时间比胃源性KT患者更长。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/49d9/4303750/255c9bd4a5ac/ogs-58-32-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/49d9/4303750/acd410eb34c9/ogs-58-32-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/49d9/4303750/4c89f7cdb949/ogs-58-32-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/49d9/4303750/bb5c497f2fb7/ogs-58-32-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/49d9/4303750/255c9bd4a5ac/ogs-58-32-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/49d9/4303750/acd410eb34c9/ogs-58-32-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/49d9/4303750/4c89f7cdb949/ogs-58-32-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/49d9/4303750/bb5c497f2fb7/ogs-58-32-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/49d9/4303750/255c9bd4a5ac/ogs-58-32-g004.jpg

相似文献

1
Krukenberg tumors of gastric origin versus colorectal origin.胃源性与结直肠源性库肯勃瘤
Obstet Gynecol Sci. 2015 Jan;58(1):32-9. doi: 10.5468/ogs.2015.58.1.32. Epub 2015 Jan 16.
2
A comparative study of RTK gene status between primary tumors, lymph-node metastases, and Krukenberg tumors.原发肿瘤、淋巴结转移灶与库肯勃瘤中 RTK 基因状态的对比研究。
Mod Pathol. 2021 Jan;34(1):42-50. doi: 10.1038/s41379-020-0636-7. Epub 2020 Jul 30.
3
Metastasectomy Improves the Survival of Gastric Cancer Patients with Krukenberg Tumors: A Retrospective Analysis of 182 patients.转移瘤切除术可提高患有库肯勃瘤的胃癌患者的生存率:一项对182例患者的回顾性分析
Cancer Manag Res. 2019 Dec 18;11:10573-10580. doi: 10.2147/CMAR.S227684. eCollection 2019.
4
Krukenberg tumours from gastrointestinal cancers-analysis from a tertiary care centre in India.来自胃肠道癌的库肯勃瘤——印度一家三级医疗中心的分析
J Gastrointest Oncol. 2018 Dec;9(6):1164-1167. doi: 10.21037/jgo.2018.07.03.
5
A retrospective study of clinicopathological characteristics and prognostic factors of Krukenberg tumor with gastric origin.胃源性库肯勃瘤临床病理特征及预后因素的回顾性研究
J Gastrointest Oncol. 2022 Jun;13(3):1022-1034. doi: 10.21037/jgo-22-464.
6
Surgical treatment for patients with different origins of Krukenberg tumors: outcomes and prognostic factors.不同起源的库肯勃瘤患者的外科治疗:疗效及预后因素
Eur J Surg Oncol. 2009 Jan;35(1):92-7. doi: 10.1016/j.ejso.2008.05.006. Epub 2008 Jul 16.
7
Krukenberg's tumour unilateral giant metachronous of colonic origin - Case report.克鲁肯伯格瘤,源于结肠的单侧巨大异时性肿瘤——病例报告
Int J Surg Case Rep. 2017;41:184-187. doi: 10.1016/j.ijscr.2017.10.029. Epub 2017 Nov 5.
8
Clinical Outcomes in Patients With Krukenberg Tumors From Colorectal Cancer.结直肠癌转移性 Krukenberg 瘤患者的临床结局。
J Surg Res. 2024 Jul;299:343-352. doi: 10.1016/j.jss.2024.04.030. Epub 2024 May 24.
9
Krukenberg Tumors of Gastric Origin: The Rationale of Surgical Resection and Perioperative Treatments in a Multicenter Western Experience.胃源性库肯勃瘤:多中心西方经验中手术切除及围手术期治疗的理论依据
World J Surg. 2016 Apr;40(4):921-8. doi: 10.1007/s00268-015-3326-8.
10
Management of Krukenberg tumors: an 11-year experience and review of the literature.库肯勃瘤的管理:11年经验及文献综述
Prim Care Update Ob Gyns. 1998 Jul 1;5(4):157-158. doi: 10.1016/s1068-607x(98)00047-x.

引用本文的文献

1
Krukenberg Tumors: Does Surgical Resection Improve Survival?库肯勃瘤:手术切除能提高生存率吗?
Indian J Surg Oncol. 2025 Feb;16(1):8-18. doi: 10.1007/s13193-024-02006-9. Epub 2024 Jul 9.
2
Krukenberg tumours: which patients should be considered for surgery?-a narrative literature review.库肯勃瘤:哪些患者应考虑手术治疗?——一篇叙述性文献综述
Transl Cancer Res. 2024 Oct 31;13(10):5664-5677. doi: 10.21037/tcr-24-904. Epub 2024 Oct 29.
3
Colorectal Origin: A Marker of Favorable Outcome in Krukenberg Tumor? Results from Clinical and Prognostic Analysis.

本文引用的文献

1
Virilizing ovarian Krukenberg tumor in a 27-year-old pregnant woman. A case report and literature review.一名27岁孕妇的男性化卵巢库肯勃瘤。病例报告及文献综述
Eur J Gynaecol Oncol. 2011;32(3):331-3.
2
The role of cytoreductive surgery for non-genital tract metastatic tumors to the ovaries.卵巢转移非生殖系统肿瘤的细胞减灭术的作用。
Eur J Obstet Gynecol Reprod Biol. 2010 Mar;149(1):97-101. doi: 10.1016/j.ejogrb.2009.11.011. Epub 2009 Dec 16.
3
Surgical treatment for patients with different origins of Krukenberg tumors: outcomes and prognostic factors.
结直肠起源:克鲁肯伯格瘤预后良好的标志物?临床及预后分析结果
South Asian J Cancer. 2024 Feb 12;13(2):99-105. doi: 10.1055/s-0043-1776789. eCollection 2024 Apr.
4
Krukenberg tumour as the initial manifestation of lung adenocarcinoma.库肯勃瘤作为肺腺癌的首发表现
Respirol Case Rep. 2023 Apr 4;11(5):e01133. doi: 10.1002/rcr2.1133. eCollection 2023 May.
5
Gastrointestinal stromal tumor metastasis to the ovary: A case report.胃肠道间质瘤转移至卵巢:一例报告。
SAGE Open Med Case Rep. 2021 Apr 29;9:2050313X211012511. doi: 10.1177/2050313X211012511. eCollection 2021.
6
The diagnosis and outcome of Krukenberg tumors.库肯勃瘤的诊断与预后
J Gastrointest Oncol. 2021 Apr;12(2):226-236. doi: 10.21037/jgo-20-364.
7
Primary mucinous ovarian tumors vs. ovarian metastases from gastrointestinal tract, pancreas and biliary tree: a review of current problematics.原发性黏液性卵巢肿瘤与胃肠道、胰腺和胆道转移至卵巢肿瘤:当前问题综述。
Diagn Pathol. 2021 Mar 11;16(1):20. doi: 10.1186/s13000-021-01079-2.
8
Prognosis and factors affecting colorectal cancer with ovarian metastasis.结直肠癌伴卵巢转移的预后及影响因素。
Updates Surg. 2021 Apr;73(2):391-398. doi: 10.1007/s13304-021-00978-9. Epub 2021 Feb 1.
9
Molecular Alterations in Metastatic Ovarian Cancer From Gastrointestinal Cancer.胃肠道癌来源的转移性卵巢癌的分子改变
Front Oncol. 2020 Dec 10;10:605349. doi: 10.3389/fonc.2020.605349. eCollection 2020.
10
Comparison of long-term oncologic outcomes between metastatic ovarian carcinoma originating from gastrointestinal organs and advanced mucinous ovarian carcinoma.胃肠道来源的转移性卵巢癌与高级别黏液性卵巢癌的长期肿瘤学结局比较。
Int J Clin Oncol. 2019 Aug;24(8):950-956. doi: 10.1007/s10147-019-01438-6. Epub 2019 Apr 2.
不同起源的库肯勃瘤患者的外科治疗:疗效及预后因素
Eur J Surg Oncol. 2009 Jan;35(1):92-7. doi: 10.1016/j.ejso.2008.05.006. Epub 2008 Jul 16.
4
[Krukenberg tumors of gastric origin versus Krukenberg tumors of colorectal origin].[胃源性库肯勃瘤与结直肠源性库肯勃瘤]
Chirurgia (Bucur). 2007 Jul-Aug;102(4):407-10.
5
An in-depth look at Krukenberg tumor: an overview.深入剖析库肯勃瘤:概述
Arch Pathol Lab Med. 2006 Nov;130(11):1725-30. doi: 10.5858/2006-130-1725-AILAKT.
6
From krukenberg to today: the ever present problems posed by metastatic tumors in the ovary: part I. Historical perspective, general principles, mucinous tumors including the krukenberg tumor.从库肯勃瘤到如今:卵巢转移性肿瘤带来的长期存在的问题:第一部分。历史视角、一般原则、黏液性肿瘤包括库肯勃瘤
Adv Anat Pathol. 2006 Sep;13(5):205-27. doi: 10.1097/01.pap.0000213038.85704.e4.
7
Krukenberg tumors of the ovary: a clinicopathologic analysis of 120 cases with emphasis on their variable pathologic manifestations.卵巢库肯勃瘤:120例临床病理分析,重点关注其多样的病理表现
Am J Surg Pathol. 2006 Mar;30(3):277-99. doi: 10.1097/01.pas.0000190787.85024.cb.
8
Survival benefit of metastasectomy for Krukenberg tumors from gastric cancer.胃癌库肯勃瘤行转移瘤切除术的生存获益
Gynecol Oncol. 2004 Aug;94(2):477-82. doi: 10.1016/j.ygyno.2004.05.007.
9
Incidence of metastasis to the ovaries from nongenital tract primary tumors.非生殖道原发性肿瘤转移至卵巢的发生率。
Gynecol Oncol. 2004 Apr;93(1):87-91. doi: 10.1016/j.ygyno.2003.12.039.
10
Metastatic ovarian tumors: a review of 64 cases.转移性卵巢肿瘤:64例病例回顾
Gynecol Oncol. 2003 May;89(2):314-7. doi: 10.1016/s0090-8258(03)00075-1.